Literature DB >> 11285971

Percutaneous endoscopic gastrostomy after abdominal surgery.

E Eleftheriadis1, K Kotzampassi.   

Abstract

BACKGROUND: Percutaneous endoscopic gastrostomy (PEG) has been established as a minimally invasive and safe procedure to provide nutritional support in patients unable to swallow food properly. However, a relative contraindication for the procedure is the existence of previous abdominal surgery.
METHOD: We described our experience in performing PEG on 37 patients who had undergone surgery for upper abdominal diseases 10 days to 25 years previously. This group of 37 patients, 22 of whom had been subjected to laparotomy in the previous 2 weeks, was compared with 291 patients who had an intact abdomen regarding failure of the procedure to be performed, major and minor complications, and mortality.
RESULTS: The two groups were found to be comparable: failure rates of 2.71% (1/37) and 1.72% (5/291), no major complications, no mortality, minor complication rates of 2.77% (1/36) and 2.44% (7/286).
CONCLUSIONS: The PEG procedure is associated with minimal risk even in patients previously subjected to upper abdominal surgery, as long as transillumination of the stomach and finger palpation are seen clearly during endoscopy.

Entities:  

Mesh:

Year:  2001        PMID: 11285971     DOI: 10.1007/s004640000250

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  20 in total

1.  Failure to transilluminate the stomach is not an absolute contraindication to PEG insertion.

Authors:  J A Stewart; P Hagan
Journal:  Endoscopy       Date:  1998-09       Impact factor: 10.093

2.  Transilluminating percutaneous endoscopic gastrostomy.

Authors:  J L Ponsky
Journal:  Endoscopy       Date:  1998-09       Impact factor: 10.093

3.  Percutaneous endoscopic gastrostomy/jejunostomy in the early postoperative period.

Authors:  I Szántó; A Vörös; K Nagy; J Kiss; L Vimláti; A Bohák
Journal:  Endoscopy       Date:  1998-01       Impact factor: 10.093

Review 4.  Percutaneous endoscopic gastrostomy: state of the art, 1998.

Authors:  J D Mellinger; J L Ponsky
Journal:  Endoscopy       Date:  1998-02       Impact factor: 10.093

5.  Percutaneous endoscopic gastrostomy: technical modifications for improved results.

Authors:  K R Dye; C P Pattison; N V Dye
Journal:  South Med J       Date:  1986-01       Impact factor: 0.954

Review 6.  Percutaneous endoscopic gastrostomy. Results in 316 patients and review of literature.

Authors:  R E Miller; B Castlemain; F J Lacqua; D P Kotler
Journal:  Surg Endosc       Date:  1989       Impact factor: 4.584

7.  Assessing the feasibility of percutaneous endoscopic gastrostomy following gastrectomy.

Authors:  A Kurchin; W Halloran; R Kornfield
Journal:  Gastrointest Endosc       Date:  1988 Jul-Aug       Impact factor: 9.427

8.  Percutaneous endoscopic gastrostomy (PEG). 8 years of clinical experience in 232 patients.

Authors:  W Amann; H J Mischinger; A Berger; G Rosanelli; W Schweiger; G Werkgartner; J Fruhwirth; H Hauser
Journal:  Surg Endosc       Date:  1997-07       Impact factor: 4.584

9.  Percutaneous endoscopic gastrostomy. Initial placement by single endoscopic technique and long-term follow-up.

Authors:  J P Grant
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

10.  External biliary-gastric fistula: a simple method for recycling bile.

Authors:  J L Ponsky; A Aszodi
Journal:  Am J Gastroenterol       Date:  1982-12       Impact factor: 10.864

View more
  3 in total

Review 1.  Enteral nutrition and mucosal immunity: implications for feeding strategies in surgery and trauma.

Authors:  David L Sigalet; Shannon L Mackenzie; S Morad Hameed
Journal:  Can J Surg       Date:  2004-04       Impact factor: 2.089

2.  Percutaneous Endoscopic Gastrostomy: Technical Problems, Complications, and Management.

Authors:  Savas Yuruker; Bulent Koca; Ilhan Karabicak; Bekir Kuru; Necati Ozen
Journal:  Indian J Surg       Date:  2015-01-23       Impact factor: 0.656

3.  Percutaneous endoscopic gastrostomy in the supermorbidly obese patient.

Authors:  Grant V Bochicchio; James L Guzzo; Thomas M Scalea
Journal:  JSLS       Date:  2006 Oct-Dec       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.